We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network.
- Authors
Giacomini, Kathleen M.; Karnes, Jason H.; Crews, Kristine R.; Monte, Andrew A.; Murphy, William A.; Oni‐Orisan, Akinyemi; Ramsey, Laura B.; Yang, Jun J.; Whirl‐Carrillo, Michelle
- Abstract
Summary statistics for many of these GWASs are available through a pharmacogenomic toolkit for PGRN members.4 Additionally, the PGRN has been involved in the development of multiple PGx resources, discussed below. The original Pharmacogenomic Research Network (original PGRN) has been the crucible of pharmacogenomics (PGx) research since its initial NIH funding in 2000. The new Pharmacogenomics Global Research Network (PGRN) is an independent society that builds on the National Institutes of Health (NIH)-funded Pharmacogenomics Research Network that was established in 2000. Pharmaceutical industry and regulatory agencies have recognized PGx as a key player in drug development and postmarketing drug optimization.
- Subjects
INDIVIDUALIZED medicine; PHARMACOGENOMICS; GENETIC variation; GENETIC mutation; HUMAN genetic variation; GENOME-wide association studies
- Publication
Clinical Pharmacology & Therapeutics, 2021, Vol 110, Issue 3, p559
- ISSN
0009-9236
- Publication type
Article
- DOI
10.1002/cpt.2340